Induction Strategy for Locally Advanced Thymoma

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Aug 9

PMID 34367988

Citations 7

Authors

Yang Zhang

Zongjuan Li

Yixing Chen

Lijie Tan

Zhaochong Zeng

Jianyong Ding

Shisuo Du

Affiliations

Soon will be listed here.

Abstract

Surgery remains cornerstone for the management of thymoma. Complete surgical resection (R0), is recognized as the constant and significant factor for prognosis. However, in locally advanced (Masaoka-Koga stages III-IVa) thymomas, achieving R0 resection remains challenging due to local-regional invasion of the disease. Induction treatment, with the aim of reducing bulky tumor mass, offers new strategy to facilitate totally surgical resection. Herein, we reviewed recent progress and provided a comprehensive overview of induction strategy in locally advance thymoma.

Citing Articles

Effectiveness of Adjuvant Chemo- and Radiotherapy in Thymic Carcinoma Stage II: A Systematic Review and Meta-Analysis.

Nazzal A, Yayan J, Biancosino C, Tabatabaei S, Hekmat K Cancer Control. 2025; 31:10732748241292781.

PMID: 39865594 PMC: 11503756. DOI: 10.1177/10732748241292781.

Impact of F-FDG PET on TNM Staging and Prognosis in Thymic Epithelial Tumors.

Akamine T, Nakagawa K, Ito K, Watanabe H, Yotsukura M, Yoshida Y Ann Surg Oncol. 2023; 31(1):192-200.

PMID: 37743455 DOI: 10.1245/s10434-023-14328-z.

Thymoma and Thymic Carcinoma: Surgical Resection and Multidisciplinary Treatment.

Zhang Y, Lin D, Aramini B, Yang F, Chen X, Wang X Cancers (Basel). 2023; 15(7).

PMID: 37046614 PMC: 10093507. DOI: 10.3390/cancers15071953.

Conventional and radiomic features to predict pathology in the preoperative assessment of anterior mediastinal masses.

Mayoral M, Pagano A, Araujo-Filho J, Zheng J, Perez-Johnston R, Tan K Lung Cancer. 2023; 178:206-212.

PMID: 36871345 PMC: 10544811. DOI: 10.1016/j.lungcan.2023.02.014.

Invasive type B2 thymoma associated with myasthenia gravis, resection with superior vena cava reconstruction.

Wilde S, Carroway W, Hsu D, Banks K, Velotta J J Surg Case Rep. 2022; 2022(9):rjac368.

PMID: 36071728 PMC: 9444289. DOI: 10.1093/jscr/rjac368.

References

Akaogi E, Ohara K, Mitsui K, Onizuka M, Ishikawa S, Mitsui T . Preoperative radiotherapy and surgery for advanced thymoma with invasion to the great vessels. J Surg Oncol. 1996; 63(1):17-22. DOI: 10.1002/(SICI)1096-9098(199609)63:1<17::AID-JSO4>3.0.CO;2-T. View

Khorfan R, Bharat A, Odell D . Management and Long-Term Outcomes of Advanced Stage Thymoma in the United States. Ann Thorac Surg. 2020; 111(1):223-230. PMC: 8452232. DOI: 10.1016/j.athoracsur.2020.05.088. View

Huang J, Ahmad U, Antonicelli A, Catlin A, Fang W, Gomez D . Development of the international thymic malignancy interest group international database: an unprecedented resource for the study of a rare group of tumors. J Thorac Oncol. 2014; 9(10):1573-8. DOI: 10.1097/JTO.0000000000000269. View

Marchevsky A, Walts A . PD-L1, PD-1, CD4, and CD8 expression in neoplastic and nonneoplastic thymus. Hum Pathol. 2016; 60:16-23. DOI: 10.1016/j.humpath.2016.09.023. View

Fujii Y . Published guidelines for management of thymoma. Thorac Surg Clin. 2010; 21(1):125-9, viii. DOI: 10.1016/j.thorsurg.2010.08.002. View

Kanzaki R, Kanou T, Ose N, Funaki S, Shintani Y, Minami M . Long-term outcomes of advanced thymoma in patients undergoing preoperative chemotherapy or chemoradiotherapy followed by surgery: a 20-year experience. Interact Cardiovasc Thorac Surg. 2018; 28(3):360-367. DOI: 10.1093/icvts/ivy276. View

Berghmans T, Durieux V, Holbrechts S, Jungels C, Lafitte J, Meert A . Systemic treatments for thymoma and thymic carcinoma: A systematic review. Lung Cancer. 2018; 126:25-31. DOI: 10.1016/j.lungcan.2018.10.018. View

Wei Y, Gu Z, Shen Y, Fu J, Tan L, Zhang P . Preoperative induction therapy for locally advanced thymic tumors: a retrospective analysis using the ChART database. J Thorac Dis. 2016; 8(4):665-72. PMC: 4824724. DOI: 10.21037/jtd.2016.03.02. View

Katsuya Y, Fujita Y, Horinouchi H, Ohe Y, Watanabe S, Tsuta K . Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma. Lung Cancer. 2015; 88(2):154-9. DOI: 10.1016/j.lungcan.2015.03.003. View

10.

Cho J, Kim H, Ku B, Choi Y, Cristescu R, Han J . Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial. J Clin Oncol. 2018; 37(24):2162-2170. DOI: 10.1200/JCO.2017.77.3184. View

11.

Cardillo G, Carleo F, Giunti R, Lopergolo M, Salvadori L, De Massimi A . Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages III and IVa). Eur J Cardiothorac Surg. 2009; 37(4):819-23. DOI: 10.1016/j.ejcts.2009.11.001. View

12.

Gomez D, Komaki R . Technical advances of radiation therapy for thymic malignancies. J Thorac Oncol. 2010; 5(10 Suppl 4):S336-43. DOI: 10.1097/JTO.0b013e3181f20ea2. View

13.

Rohrer Bley C, Meier V, Schneider U . Dosimetric benefit of adaptive radiotherapy in the neoadjuvant management of canine and feline thymoma-An exploratory case series. Vet Comp Oncol. 2018; 16(3):324-329. DOI: 10.1111/vco.12382. View

14.

Darby S, McGale P, Taylor C, Peto R . Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005; 6(8):557-65. DOI: 10.1016/S1470-2045(05)70251-5. View

15.

Kim E, Putnam J, Komaki R, Walsh G, Ro J, Shin H . Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer. 2004; 44(3):369-79. DOI: 10.1016/j.lungcan.2003.12.010. View

16.

Ohara K, Tatsuzaki H, Fuji H, Sugahara S, Okumura T, Akaogi E . Radioresponse of thymomas verified with histologic response. Acta Oncol. 1998; 37(5):471-4. DOI: 10.1080/028418698430421. View

17.

Korst R, Bezjak A, Blackmon S, Choi N, Fidias P, Liu G . Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial. J Thorac Cardiovasc Surg. 2013; 147(1):36-44, 46.e1. DOI: 10.1016/j.jtcvs.2013.08.061. View

18.

Song J, Kim D, Kwon J, Kim H, Choi C, Jang S . Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors. Front Oncol. 2019; 9:1055. PMC: 6803548. DOI: 10.3389/fonc.2019.01055. View

19.

Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C . Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313(5795):1960-4. DOI: 10.1126/science.1129139. View

20.

Ohara K, Okumura T, Sugahara S, Akisada M, Yokose T, Ogata T . The role of preoperative radiotherapy for invasive thymoma. Acta Oncol. 1990; 29(4):425-9. DOI: 10.3109/02841869009090025. View